“What could it be? My hope is that they filed the equivalent to our HIV BLA in the U.K. and the clock will start ticking for approval.”

IMO, this seems unlikely. Investors were just informed last week that the MHRA outlined the 350mg BLA details. I find it hard to believe that Amarex put the U.K. BLA together in just over a week, especially considering they’re also focused on the US BLA and the S/C trial.